rare diseases
Rare diseases and orphan drugs in eastern european countries
5
Rare diseases in China: analysis of 2014–2015 hospitalization summary reports for 281 rare diseases from 96 tertiary hospitals
8
From scientific discovery to treatments for rare diseases – the view from the National Center for Advancing Translational Sciences – Office of Rare Diseases Research
8
A comparison of interventional clinical trials in rare versus non-rare diseases: an analysis of ClinicalTrials.gov
11
Rare diseases website Developing the Parent to Parent Content of a Rare Disease Website in Ireland
86
A population-based registry as a source of health indicators for rare diseases: the ten-year experience of the Veneto Region’s rare diseases registry
12
The italian approach to rare diseases and the action of the Italian National Centre for Rare Diseases
6
Analyzing rare diseases terms in biomedical terminologies
15
Rare Diseases: understanding this Public Health Priority
14
The European Union action in the field of rare diseases
7
Strategies for eliciting and synthesizing evidence for guidelines in rare diseases
10
Social Media Methods for Studying Rare Diseases
11
The availability and affordability of orphan drugs for rare diseases in China
12
A first description of the Colombian national registry for rare diseases
7
Characteristics of patients contacting a center for undiagnosed and rare diseases
9
Insights into rare diseases from social media surveys
5
NLP can help parents to understand rare diseases
10
Rare Diseases in India: Current Knowledge and New Possibilities
5
WA Rare Diseases Strategic Framework
36
SpainUDP: The Spanish Undiagnosed Rare Diseases Program
15